The Regulator

August 24: that is when the Justice Department formally moves health care fraud prosecutions into a division built specifically to chase them, under a final rule it published today. The Department of Justice (DOJ) published a final rule in the Federal Register on August 18, 2026 amending Part 0 of its organizational regulations in title 28 of the Code of Federal Regulations to formally establish the National Fraud Enforcement Division, effective August 24, 2026. The rule, issued under Docket No. OAG207 and Attorney General Order No. 7108-2026, assigns the new division authority over “criminal proceedings involving fraud or abuse with respect to health plans” and “criminal proceedings related to health care fraud and controlled substances distribution and diversion schemes,” stripping that jurisdiction from the department’s Criminal Division. It also grants the division a broad scope-expansion power to prosecute “any criminal offenses identified” during an investigation “whether or not such prosecution” fits its original mandate, and lets its leadership certify special grand juries in any federal district. The rule follows an August 13 memo from the division’s assistant attorney general naming healthcare fraud a top priority as the division staffs up to roughly 500 attorneys and support staff, and it issued without the usual notice-and-comment period because DOJ classified it as a rule of agency organization. Confidence: High. This run reviewed the Federal Register document directly. Sources: Establishing the National Fraud Enforcement Division, Federal Register, DOJ Establishes National Fraud Enforcement Division, Holland & Knight.

1:26-cv-02723: that is the case number a federal judge inherited this week in a lawsuit over the Trump administration’s decision to strip gender-affirming care from federal employees’ health coverage. Five federal workers, suing under pseudonyms, filed a proposed class action in the U.S. District Court for the District of Columbia on August 3, 2026 against Office of Personnel Management (OPM) Director Scott Kupor, represented by the Human Rights Campaign Foundation along with the firms Correia & Puth and Cohen Milstein Sellers & Toll. The suit challenges an OPM directive, effective January 1, 2026, that ordered Federal Employees Health Benefits (FEHB) and Postal Service Health Benefits (PSHB) plans to exclude coverage for gender-affirming procedures, arguing the exclusion amounts to sex discrimination barred by Title VII of the Civil Rights Act of 1964 under the Supreme Court’s 2020 Bostock v. Clayton County precedent. The court approved the plaintiffs’ pseudonym motion August 14 and assigned the case to U.S. District Judge Amit Mehta on August 17; the plaintiffs are seeking class certification and an order blocking enforcement of the coverage exclusion. A July 2026 Williams Institute analysis estimated between roughly 39,400 and 57,800 transgender people receive coverage through federal employee health plans nationally. Confidence: High on the docket facts, drawn from the court record; Medium on the affected-population estimate, which reflects independent academic modeling rather than an OPM-published figure. Sources: Doe v. Kupor, Docket No. 1:26-cv-02723, U.S. District Court for the District of Columbia via CourtListener, Federal Employee Health Benefits Class Action, Human Rights Campaign.

7 days: that is the new maximum window for HIV and West Nile virus blood tests on every living kidney and liver donor, under an emergency organ-transplant policy that took effect this week. The Organ Procurement and Transplantation Network (OPTN), the federally contracted body that governs US transplant policy, implemented an emergency rule effective August 17, 2026 shortening the serology testing window for HIV from 28 days to 7 days and for seasonal West Nile virus from 14 days to 7 days, and expanded the tightened deadline to cover all 17 required serology and final crossmatch tests for kidney and liver donations. OPTN President John Magee announced the change, which transplant registries say is intended to close the gap between when a living donor is tested and when transplant surgery occurs, reducing the chance a donor’s infection status changes between test and transplant. The National Kidney Registry, a network connecting transplant centers nationwide, said it began operating under the tighter standard a week early, on August 10, to give centers time to adjust. Confidence: Medium. This run could not independently retrieve OPTN’s own policy notice, which returned an access error, but transplant-industry trade coverage reviewed and quoted the policy directly. Sources: OPTN Policy Notice: Seasonal WNV Testing Required for All Donors, Health Resources and Services Administration, National Kidney Registry Adopts Seven-Day Serology Testing Policy, CLP Magazine.

August 17: that is when the comment window closed on a CMS (Centers for Medicare and Medicaid Services) rule meant to stop drugmakers from dodging Medicare’s price negotiation program through reformulation. CMS’s proposed rule (CMS-4215-P), published in the Federal Register June 16, 2026, would make the Medicare Drug Price Negotiation Program’s operating framework permanent and close what the agency calls loopholes, including aggregating fixed-combination drugs reformulated for a different route of administration, such as adding hyaluronidase to switch a drug from intravenous to subcutaneous delivery, with their original versions so both are subject to the same negotiated price. The rule would also let CMS impose civil monetary penalties on manufacturers without first requiring them to correct a deficiency, expand reporting requirements around mergers and acquisitions involving negotiated drugs, and shorten the timeline manufacturers get to fix pricing errors; it proposes ending the program’s small-biotech exception after 2028 and setting a temporary pricing floor near 66 percent of a drug’s non-federal average manufacturer price for 2029 and 2030. Public comments closed August 17, 2026, and CMS has said it expects to finalize the rule this fall, ahead of the February 1, 2027 deadline for publishing the next round of drugs selected for 2029 negotiations. Confidence: High. This run reviewed the Federal Register filing directly. Sources: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, Federal Register, CMS Issues First Proposed Rule for IRA Medicare Drug Price Negotiation, Holland & Knight.

24,000: that is how many cyclosporiasis illnesses the CDC has now linked to a lettuce-driven outbreak that has become the largest in US surveillance history, with Michigan hit hardest. The Centers for Disease Control and Prevention (CDC) has tracked more than 24,000 domestically acquired cyclosporiasis illnesses since May 1, 2026, including 13,895 laboratory-confirmed cases as of August 10 and roughly 10,455 more still under review, across at least 17 states; the agency’s most recent published update, posted August 13, added Maine and Massachusetts to the outbreak’s footprint. The Food and Drug Administration’s (FDA) traceback investigation identified shredded iceberg lettuce from Taylor Farms de Mexico, recalled July 17, 2026, as the source, with illnesses first clustering around Taco Bell locations before the contaminated product reached other restaurants and retailers. Michigan alone has logged 13,909 cases as of August 13, more than any other state and roughly three times the entire national case count from 2019, the prior worst year on record; nationally the outbreak has produced hundreds of hospitalizations and two deaths, both Michigan patients with significant underlying health conditions. Confidence: High on the outbreak’s scale and food source, drawn from CDC and FDA’s own outbreak-tracking pages, though this run’s direct attempts to retrieve those pages returned access errors; multiple outlets reviewed the same CDC and FDA data directly. Sources: Investigation Update: Cyclospora Outbreak, CDC, Investigation of Multistate Outbreak of Cyclospora Illnesses: Iceberg Lettuce, FDA, Cyclospora Outbreak Linked to Recalled Lettuce Grows to 9,481 Illnesses in 17 States, Quality Assurance & Food Safety.